from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1658/argG

LFCtreatmentdescriptionclass of inhibitor

-0.160

Amikacinug/mL Amikacintranslation

-0.164

Cap5-10ug/mL Capreomycintranslation

0.256

Rox10-50 ug/mL Roxithromycintranslation

-0.391

SM2-5 ug/mL Streptomycintranslation

-0.393

Tet5-10 ug/mL Tetracyclinetranslation

0.195

Rif0.2-5ug/mL Rifampicintranscription

-0.261

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.202

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.479

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.336

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.486

Clofazimine10-13 ug/mL Clofaziminerespiration

0.239

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.120

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.516

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.439

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.152

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.222

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.580

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.397

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.752

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.659

KCN5-20 ug/mL Potassium cyaniderespiration

1.884

NaN30.2-2 mM Sodium aziderespiration

0.911

Nigericin50 uM Nigericinrespiration

-0.668

TRC10-150 ug/mL Triclosanrespiration

-1.634

TRZ10-25 ug/mL Thioridazinerespiration

-0.814

Valinomycin0.5-10 uM Valinomycinrespiration

0.627

ZnSO42 mM ZnSO4respiration

-1.755

menadione6-10 ug/mL Menadionerespiration

0.365

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.072

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.393

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.102

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.889

NRP_1Non-replicating persistence stage 1dosRassociated

0.395

Amp0.2mg/mL AmpicillincellWall

0.064

Cephalexin20-100 ug/mL CephalexincellWall

-0.022

Cerulenin0.32-5 ug/mL CerulenincellWall

0.013

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.310

EMB10-20 ug/mL EthambutolcellWall

0.130

Eta12-40 ug/mL EthionamidecellWall

0.459

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.215

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.425

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.325

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.424

BZA0.12 mg/mL BenzamidearomaticAmides

0.450

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.612

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.260

H2O24 mM hydrogen peroxideDNAdamaging

-0.121

Levo10 ug/mL LevofloxacinDNAdamaging

0.644

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.801

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.166

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.487

UVUV-irradiationDNAdamaging

-1.078

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.062

Antimycin12.5-50 ug/mL Antimycin A?

0.277

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.318

PA_110-50 ug/mL Antitubercular compound PA-1?

0.022

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.634

PA8240.2-2 ug/mL PA-824?

-0.138

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.516

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.557

Verapamil50 uM Verapamil?

1.911

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.488

methoxatin10-20 ug/mL Methoxatin?